Department of Health and Social Care

The Government is committed to bringing back the family doctor for patients who would likely benefit from seeing the same clinician regularly. In doing so, we will improve continuity of care, which is associated with better health outcomes and fewer Accident and Emergency attendances.

Through our 10-Year Health Plan, it will be easier and faster to see a general practitioner. We will end the 8am scramble for appointments, train more doctors and guarantee consultations within 24 hours for those who need one. These measures will help practices offer both continuity where it’s needed and timely access for all patients.

We will give integrated care boards as commissioners the power to determine what is best for their local population and will not gatekeep specific arrangements. We will work with the profession to ensure the benefits of at scale working and continuity are combined effectively.

Our aim of establishing a Neighbourhood Health Centre (NHC) in every community, open at least 12 hours a day and 6 days a week, and with services that are fully data and digitally enabled, will revitalise access to general practice.

To establish NHCs, we will use public capital to update and refurbish existing, under-used buildings, maximising value for money and delivering healthcare closer to home for those that need it the most. Integrated care boards will be key as strategic commissioners in identifying where NHCs are required and defining their requirements in the context of other supporting infrastructure in the local area.

We are investing an additional £102 million of capital funding to upgrade existing general practice premises this year. Further details about how we will deliver NHCs and continue to invest in general practice will be confirmed in due course.

The Government recognises that pharmacies, including in Ely and East Cambridgeshire, are an integral part of the fabric of our communities, as an easily accessible ‘front door’ to the National Health Service, staffed by highly trained and skilled healthcare professionals.

Local authorities are required to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from the new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA. If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, ICBs can commission a new pharmacy to open outside of the market entry processes and can fund the contract from the ICBs’ budgets. In some rural areas where a pharmacy may not be viable, local general practices are permitted to dispense medicines to their patients. In addition, patients can choose to access medicines through any of the distance selling pharmacies that are required to deliver the medicines they dispense free of charge, and which also provide other pharmaceutical services remotely.

The Government recognises that pharmacies, including in Ely and East Cambridgeshire, are an integral part of the fabric of our communities, as an easily accessible ‘front door’ to the National Health Service, staffed by highly trained and skilled healthcare professionals.

Local authorities are required to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from the new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA. If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, ICBs can commission a new pharmacy to open outside of the market entry processes and can fund the contract from the ICBs’ budgets. In some rural areas where a pharmacy may not be viable, local general practices are permitted to dispense medicines to their patients. In addition, patients can choose to access medicines through any of the distance selling pharmacies that are required to deliver the medicines they dispense free of charge, and which also provide other pharmaceutical services remotely.

In the past three years, the number of face-to-face GP appointments were as follows:

• 12 months to August 2023: 100.1 million appointments
• 12 months to August 2024: 101.2 million appointments
• 12 months to August 2025: 99 million appointments

These appointments do not include COVID-19 vaccinations, and a small number of Primary Care Network appointments that could not be allocated to an integrated care board have been excluded.

We appreciate the work undertaken and the findings presented in the Unfair to Care 2025 report. We are committed to supporting adult social care workers, turning the page on decades of low pay and insecurity. That is why we plan to introduce the first ever Fair Pay Agreement in 2028, backed by £500 million of funding to improve pay and conditions for the adult social care workforce.

The Impact Assessment for the Employment Rights Bill, published in October 2024, provides an initial, indicative assessment of the impacts that could result from primary legislation. This represents the best estimate for the likely impacts of a Fair Pay Agreement given the current stage of policy development.

The Spending Review 2025 allows for over £4 billion in additional funding available for ASC in 2028-29 compared to 2025-26. This includes other sources of income available to support adult social care, additional grant funding and an increase in the National Health Service’s contribution to adult social care via the Better Care Fund. This £4 billion increase includes £500 million to begin implementing the Fair Pay Agreement in 2028-29.

National supervised toothbrushing programme funding and free dental products are based on the Office for National Statistics’ Indices of Multiple Deprivation mid-2020 population estimates. These were used to identify the number of three to five-year-olds living in the 20% most deprived Lower Super Output Areas of local authorities, including Buckinghamshire Council and Milton Keynes City Council.

There are no current plans to change the way that primary care network (PCN) accounts, where required, are published. There is no requirement for practices to form separate legal entities when establishing a PCN account, and the Directed Enhanced Service is held by individual practices. Where local arrangements have led to the creation of separate legal entities, they are covered by existing company law and requirements to produce accounts.

The Department’s settlement announced at Spending Review (SR) 2025 means that annual National Health Service day-to-day spending will increase by £29 billion in real terms (£53 billion cash increase) by 2028-29 compared to 2023-24. This will take the NHS resource budget to £226 billion by 2028-29, equivalent to a 3.0% average annual real terms growth rate over the SR period.

The detail of SR budget allocations within departments is still being determined and we are working to provide the detail and certainty needed on future funding and spending plans.

This includes preparing for the first medium-term planning round for the NHS in more than half a decade, which will give local leaders the certainty they need to deliver.

The Golden Hello scheme aims to support dental practices in areas that are experiencing significant dental pressures, including areas with no National Health Service dentists.

The scheme is designed to encourage relocation to areas with workforce challenges, to attract new workers to the NHS, and to retain those who might have otherwise moved into private practice.

Under the Government’s 10-Year Health Plan, carers will be actively involved in the care planning of those they care for, mirroring the practices of family group conferencing.

Additionally, we are increasing the information captured about unpaid carers throughout the health and care system to help us better understand responsibilities and provide more targeted support. Development of a new ‘MyCarer’ section of the NHS App will also allow people to communicate more easily with relevant clinical team members on behalf of those for whom they care.

To provide further support, in April, the Government increased the Carer’s Allowance weekly earnings limit from £151 a week to £196, the largest ever increase since the Carer’s Allowance was introduced in 1976.

As of 31 August 2025, 48 newly qualified GPs have been recruited through the Additional Roles Reimbursement Scheme since October 2024 in NHS Bedfordshire, Luton and Milton Keynes Integrated Care Board.

Supervised toothbrushing is an evidence-based intervention. The most recent assessment suggests that supervised toothbrushing schemes have a five-year return on investment of £3.06 for every £1 spent where the rate of decayed, missing due to decay, and filled teeth is two or greater. Further information is available at the following link:

https://www.gov.uk/government/publications/improving-the-oral-health-of-children-cost-effective-commissioning

The Government is considering the outcomes of the consultation and will publish a response in due course.

General practices are independent businesses contracted to provide National Health Service services. As self-employed contractors to the NHS, it is for GP practices to determine uplifts in pay for their employees.

We are investing an additional £1.1 billion in general practice to reinforce the front door of the NHS, bringing total spend on the GP Contract to £13.4 billion in 2025-26, the biggest cash increase in over a decade. The 8.9% boost to the GP contract in 2025/26 is greater than the 5.8% growth to the NHS budget as a whole.

The independent review body on Doctors’ and Dentists’ Remuneration (DDRB) recommended an uplift of 4% to the pay ranges for salaried GPs, and to GP contractor pay. As with last year, we have accepted the DDRB’s pay recommendation and have uplifted the pay elements of the GP contract by 4% on a consolidated basis (an increase of 1.2% on top of the 2.8% interim uplift in April).

Funding for these awards will be backdated to April 2025. We expect General Practice Contractors to implement pay rises to other practice staff in line with the uplift in funding they are receiving.

Funding for 2025/26 has been allocated at upper tier local authority level. For Buckinghamshire Council and Milton Keynes City Council this was £61,842.36 for supervised toothbrushing in early years settings. Further information is available at the following link:

https://www.gov.uk/government/publications/public-health-grants-to-local-authorities-2025-to-2026

Local authorities are required, by statute, to undertake a pharmaceutical needs assessment (PNA) every three years to assess whether their population is adequately served by local pharmacies and must keep these assessments under review. Integrated care boards (ICBs) give regard to the PNAs when reviewing applications from the new contractors. Contractors can also apply to open a new pharmacy to offer benefits to patients that were not foreseen by the PNA.

If there is a need for a new local pharmacy to open and no contractors apply to open a pharmacy and fill the gap, an ICB can commission a new pharmacy to open outside of the market entry processes and fund the contract from the ICB’s budgets. In some rural areas where a pharmacy may not be viable, local GP practices are permitted to dispense medicines to their patients. In addition, patients can choose to access medicines through any of the distance selling pharmacies that are required to deliver medicines they dispense free of charge and also provide other pharmaceutical services remotely.

As announced in the 10-Year Health Plan, we will make it a requirement for newly qualified dentists to practice in the National Health Service for a minimum period which we intend to be at least three years. That will mean more NHS dentists, more NHS appointments and better oral health.

Later this year we will publish a 10-Year Workforce Plan to create a workforce ready to deliver a transformed service. They will be more empowered, more flexible and more fulfilled.

We expect neighbourhood teams and services to be designed in a way that reflects the specific needs of local populations. While we will be clear on the outcomes we expect, we will give significant licence to tailor the approach to local need. While the focus on personalised, coordinated care will be consistent, that will mean the service will look different in rural communities, coastal towns or deprived inner cities.

Later this year we will publish a 10-Year Workforce Plan to create a workforce ready to deliver a transformed service. They will be more empowered, more flexible and more fulfilled.

As announced in the 10-Year Health Plan, we will now make it a requirement for newly qualified dentists to practice in the National Health Service for a minimum period, intended to be at least three years. We will consult on the detail of this proposal in due course.

The Government announced in the 10 Year Infrastructure Strategy document on 19 June 2025, as well as in the 10-Year Health plan published on 3 July 2025, that it will explore the feasibility of using new Public Private Partnerships (PPPs) to deliver certain types of primary and community health infrastructure, including neighbourhood health centres. The business case is being co-developed by the Department of Health and Social Care and the National Infrastructure and Service Transformation Authority. The decision on whether to proceed with the use of PPPs for neighbourhood health centres will be made by HM Treasury and relevant ministers by the 2025 Autumn Budget.

The Government has recognised that, nationally, demand for assessments for attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays accessing such assessments.

It is the responsibility of the integrated care boards (ICBs) in England to make available appropriate provision to meet the health and care needs of their local population, including providing access to ADHD assessment and treatment, in line with relevant National Institute for Health and Care Excellence guidelines.

NHS England established an ADHD taskforce which brought together those with lived experience with experts from the NHS, education, charity, and justice sectors to get a better understanding of the challenges affecting those with ADHD, including in accessing services and support. An interim report was published on 20 June, with the final report expected later this year, and we will carefully consider its recommendations.

The NHS South Yorkshire ICB advises that the Sheffield Adult Autism and Neurodevelopmental Service is reviewing its diagnostic pathways and recruiting additional staff in order to improve efficiency within the service. The NHS South Yorkshire ICB has also commissioned the Adult Autism and ADHD Support Hub, delivered by the voluntary sector organisation, Mental Health Matters, to offer free support to autistic people and people with ADHD living in Sheffield. The hub provides a range of practical advice and information on areas such as confidence building, peer support, and wellbeing.

The Government has recognised that, nationally, demand for assessments for attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays in accessing such assessments.

It is the responsibility of the integrated care boards (ICBs) in England to make available the appropriate provision to meet the health and care needs of their local population, including providing access to ADHD assessment and treatment, in line with relevant National Institute for Health and Care Excellence guidelines.

NHS England established an ADHD taskforce which brought together those with lived experience with experts from the NHS, education, charity, and justice sectors to get a better understanding of the challenges affecting those with ADHD, including in accessing services and support. An interim report was published on 20 June, with the final report expected later this year. We will carefully consider its recommendations.

For the first time, NHS England published management information on ADHD waits at a national level on 29 May 2025 as part of its ADHD data improvement plan and has also released technical guidance to ICBs to improve the recording of ADHD data, with a view to improving the quality of ADHD waits data and to publishing more localised data in future. NHS England has also captured examples from ICBs who are trialling innovative ways of delivering ADHD services and is using this information to support systems to tackle ADHD waiting lists and provide support to address people’s needs.

The NHS is implementing various preventative services to support older people in maintaining their health and independence.

These services include:

• Support for frailty: The NHS Toolkit for General practice in supporting older people living with frailty offers tools to GPs and practice staff to identify and manage frailty in patients aged 65 and over.
• Integrated care systems: The NHS 10 Year Plan aims to move care from hospitals into communities, bringing together health and care professionals to provide proactive care and prevention services.
• Preventive primary care: Preventive primary care interventions are being evaluated to improve functional ability and self-rated health for older people.

These initiatives are part of a broader strategy to improve the quality of care and prevent unnecessary hospital admissions for older people. The NHS is working with partners across health and social care to ensure that older people receive the highest quality care when they need it.

Norfolk and Waveney ICB, working with Norfolk County Council, local authorities, the voluntary sector, and NHS providers, has established a wide range of preventative services to help older people live healthier, more independent lives. The ICB’s Protect NoW programme is tackling inequalities and improving access to health and care services through Population Health Management (PHM) and risk stratification. Projects include improving access to talking therapies, falls prevention, and the Dementia North Norfolk programme, which connects people to housing, benefits, social activities, and carers’ support.

In addition, the Health Connect initiative has supported over 9,000 residents after hospital discharge, reducing the risk of readmission through practical, emotional, health, and social support.

Histotripsy is a non-invasive ultrasound treatment that destroys tumours without the need for surgery or radiation. It was one of eight transformative technologies supported through the Government’s Innovative Devices Access Pathway (IDAP) pilot. This programme aimed to streamline patient access to medical devices that address an unmet clinical need in the National Health Service.

Through the IDAP, an Unmet Clinical Need Authorisation was granted by the Medicines and Healthcare products Regulatory Agency, exempting the manufacturer from certain regulatory requirements under specific conditions given the critical unmet need of liver cancer, allowing early market access. Histotripsy is now available for conditional use in the NHS for patients with liver tumours. NHS treatments will begin in October 2025 as a first in Europe, strengthening the United Kingdom’s position as a global leader in medical innovation.

The Minister of State for Care is currently having discussions with NHS England and Department officials about the funding arrangements for children and young people’s hospices in 2026/27. We hope to be able to provide further communication on this later in the year.

Ministers in the Department have had 15 meetings with the sponsors of the Terminally Ill Adults (End of Life) Bill, namely the Hon. Member Kim Leadbeater and Lord Falconer of Thoroton.

The Secretary of State for Health and Social Care and the Minister of State for Health meet regularly with individual Agenda for Change (AfC) trade union leaders and with representatives of NHS organisations to discuss matters affecting the NHS workforce.

It is not usual practice for Ministers to attend NHS Staff Council meetings, which are used to discuss policy issues affecting the AfC workforce and to maintain the NHS terms and conditions of service. Accordingly, there have been no meetings between the Secretary of State and the NHS Staff Council as a whole since 1 January.

Both ministers have written to the NHS Staff Council on issues relating to AfC pay, terms, and conditions since 1 January, and Department officials continue to attend meetings of the NHS Staff Council.

The independent commission into adult social care, chaired by Baroness Louise Casey of Blackstock, commenced its work in April. The Terms of Reference have been published and are designed to be sufficiently broad to enable Baroness Casey to independently consider how to build a social care system fit for the future.

The Terms of Reference are clear that recommendations should be considered within the context of the ongoing National Health Service reforms and, in phase 1, should focus on how to get adult social care working more closely with the NHS. Baroness Casey will do this by considering the existing funding for local authority adult social care services together with NHS funding for services at the interface of health and care and whether they are being best used.

The National Health Service delivers a range of treatments for cancer, with expert clinicians working with patients to determine the most appropriate option. The Government is working with NHS England to ensure that the most effective treatments are available to patients across the country when they need them.

Stereotactic ablative body radiotherapy (SABR) is routinely available to treat several types of cancer, including some types of lung cancer, pancreatic cancer, and liver cancer. Every NHS trust that is commissioned to provide radiotherapy services in England can offer SABR. However, not all cancer types can be treated with SABR in every radiotherapy service, because some trusts may not host the relevant specialist multi-disciplinary team.

No assessment has been made of the potential for systemic anti-cancer therapies to be delivered via primary care in the community or at home. However, in line with the Government’s Health Mission shift from hospital to community, the 10-Year Health Plan committed to deliver more urgent care in the community, in people’s homes, or through neighbourhood health centres by 2035.

The National Health Service delivers a range of treatments for cancer, with expert clinicians working with patients to determine the most appropriate option. The Government is working with NHS England to ensure that the most effective treatments are available to patients across the country when they need them.

Stereotactic ablative body radiotherapy (SABR) is routinely available to treat several types of cancer, including some types of lung cancer, pancreatic cancer, and liver cancer. Every NHS trust that is commissioned to provide radiotherapy services in England can offer SABR. However, not all cancer types can be treated with SABR in every radiotherapy service, because some trusts may not host the relevant specialist multi-disciplinary team.

No assessment has been made of the potential for systemic anti-cancer therapies to be delivered via primary care in the community or at home. However, in line with the Government’s Health Mission shift from hospital to community, the 10-Year Health Plan committed to deliver more urgent care in the community, in people’s homes, or through neighbourhood health centres by 2035.

The National Health Service delivers a range of treatments for cancer, with expert clinicians working with patients to determine the most appropriate option. The Government is working with NHS England to ensure that the most effective treatments are available to patients across the country when they need them.

Stereotactic ablative body radiotherapy (SABR) is routinely available to treat several types of cancer, including some types of lung cancer, pancreatic cancer, and liver cancer. Every NHS trust that is commissioned to provide radiotherapy services in England can offer SABR. However, not all cancer types can be treated with SABR in every radiotherapy service, because some trusts may not host the relevant specialist multi-disciplinary team.

No assessment has been made of the potential for systemic anti-cancer therapies to be delivered via primary care in the community or at home. However, in line with the Government’s Health Mission shift from hospital to community, the 10-Year Health Plan committed to deliver more urgent care in the community, in people’s homes, or through neighbourhood health centres by 2035.

Potential cost savings to the National Health Service from the expansion of Fracture Liaison Services will be taken into consideration in future policy development.

NHS England works to ensure that core public information on screening is easily accessible and understandable to the public, and it regularly and systematically reviews this information.

Earlier this year, NHS England updated its cervical screening guidance to include that cervical screening is not a check for other cancers of the reproductive system, such as ovary, womb, vulval, or vaginal cancer. This guidance is available at the following link:

https://www.gov.uk/government/publications/cervical-screening-description-in-brief/cervical-screening-helping-you-decide--2

The guidance advises that you should not wait to contact a general practitioner if you have any concerns.

The National Institute for Health and Care Excellence (NICE) charges companies for the development of its technology appraisal and highly specialised technologies recommendations on medicines and other health technologies. Where a company does not participate in the NICE appraisal process, the default National Health Service position will be to not routinely commission the intervention for the stated indication. This is to avoid a potential pathway for circumventing the NICE process. In some cases, such as where there is no single company that markets the medicine or technology under evaluation, NICE evaluations can be funded from other sources, such as from NICE’s core Government funding or NHS England.

My Rt Hon. Friend, the Secretary of State for Health and Social Care has not discussed zero-rating defibrillators for VAT with my Rt. Hon. Friend, the Chancellor of the Exchequer.

The Government provides VAT reliefs to aid with the purchase of automated external defibrillators (AEDs) through VAT refunds on purchases made by local authorities, including parish councils, and VAT reliefs for purchases made through voluntary contributions where the AED is donated to eligible charities or the National Health Service.

We inherited a broken National Health Service, and reducing elective waiting lists is a key part of getting it back on its feet and building an NHS that is fit for the future. To that end we have committed to achieving the NHS constitutional standard that 92% of patients should wait no longer than 18 weeks from Referral to Treatment by March 2029. Cutting waiting times for diagnostic tests such as blood tests is a crucial step in reducing the elective waiting list.

Blood tests are among the most commonly requested diagnostic investigations across primary and secondary care, and they are readily available across all 27 NHS pathology networks. Phlebotomy, the procedure to collect blood samples, is widely available across general practice, community health services, and secondary care phlebotomy clinics, supporting equitable access to blood testing.

The NHS is taking steps to reduce wait times for blood tests. These include establishing more straight to test pathways, whereby a patient is referred straight to a diagnostic test without the need for an additional outpatient appointment first, as well as investing in digital pathology and automation of histopathology services to reduce the time patients wait for blood test results to be processed.

Alongside this, we are continuing to invest in expanding diagnostic capacity in the NHS. As set out in the Elective reform Plan, we plan to build up to five more community diagnostic centres (CDCs) in 2025/26, alongside increasing the operating hours of existing sites so that more offer services 12 hours a day, seven days a week. This is backed by part of the £600 million of capital for diagnostic services announced at the October Spending Review.

CDCs offer local populations, including children, a wide range of diagnostic tests closer to home and greater choice on where and how they are undertaken. This reduces the need for hospital visits, reduces pressure on hospitals, and speeds up diagnosis. CDCs are expected to offer their services to children and young people where it is safe and appropriate to do so. Phlebotomy is a core service provided by all standard and large model CDCs.

I refer the hon. Member to the answer I gave on 13 October 2025 to Question 75637.

The UK National Screening Committee (UK NSC) and its secretariat have adopted several robust strategies that support responsiveness to innovation in screening.

The committee uses the expertise of its research and methodology group to help researchers focus the design of screening research to ensure it addresses questions in a way that is useful for screening policy. Where screening research trials are ongoing, the secretariat maintains close contact with researchers to ensure that we are proactive in response to the results coming out of the trial.

Where there are evidence gaps in screening research, in-service evaluations provide an innovative solution to generating high quality evidence for the UK NSC in live National Health Services. The UK NSC secretariat works closely with NHS England on upcoming work so that the NHS can optimise their preparations in their readiness for the implementation of recommendations agreed by ministers.

Networking across the healthcare landscape both nationally and internationally helps to ensure that the UK NSC keeps abreast of developments in screening and identifies viable innovations in tests and treatments that are suitable in the context of the United Kingdom. Collaboration between organisations such as the National Institute for Health and Care Research, the National Institute for Health and Care Excellence, the Scottish Intercollegiate Guidelines Network, and professional bodies such as the Royal College of Obstetricians and Gynaecologists supports joined up working with partners and avoids unnecessary duplication.

The Department and NHS England are taking a number of steps to support the National Health Service to deliver cost-effective prehabilitation and rehabilitation services.

NHS England has highlighted the positive impact of efficient prehabilitation and rehabilitation on cancer outcomes and the potential to lead to cost savings. The ‘PRosPer’ cancer prehabilitation and rehabilitation learning programme, launched as a partnership between NHS England and Macmillan Cancer Support, aims to support allied health professionals and the wider healthcare workforce in developing their skills in providing prehabilitation and rehabilitation as essential elements of cancer treatment.

The National Cancer Plan, to be published later this year, will look at how to improve patient outcomes across the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, including prehabilitation and rehabilitation services where appropriate.

The latest data, from July 2025, shows that 61.6% of waits for cardiology services are within 18 weeks, which is a 1.7% improvement on the same month from the previous year. While this shows progress, we know there is more to do to reduce waiting times for heart health pathways. That is why, along with our commitment to returning to the 92% referral-to-treatment standard for elective care by March 2029, the Elective Reform Plan commits to significant elective reform in cardiology.

Cardiology is one of five priority specialties identified for significant elective reform in the Elective Reform Plan. Reforms will include increasing specialist cardiology input earlier in patient care pathways and developing standard and efficient care pathways for common cardiology symptoms. It also includes improving access to cardiac diagnostic tests through implementing more ‘straight-to-test’ pathways, where a general practitioner can refer a patient directly to secondary care for a test. This can reduce unnecessary outpatient appointments and improve waiting times even further for patients across England.

These improvements to common cardiology pathways help standardise patient care, reduce inequalities, and improve access to care, especially in the early stages of heart health pathways for patients across England.

We are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care.

We are also providing £26 million of revenue funding to support children and young people’s hospices for 2025/26. This is a continuation of the funding which until recently was known as the children and young people’s hospice grant. Two children’s hospices based in Kent, Demelza Hospice and Ellenor Hospice, are receiving £1,750,000 and £189,000 respectively.

I am currently having discussions with NHS England and Department officials about the funding arrangements for children and young people’s hospices throughout England beyond 2025/26. We hope to be able to provide further communication on this later this autumn.

The Department and NHS England are currently looking at how to improve the access, quality, and sustainability of all-age palliative and end of life care in line with the 10-Year Health Plan.

The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for determining whether its guidelines should be reviewed or updated in light of new evidence. NICE takes a proactive approach to surveillance, monitoring for changes in the evidence base that may impact on its recommendations. Topics for new or updated guidance are considered through the NICE prioritisation process. Decisions as to whether NICE will create new, or update existing, guidance are overseen by a prioritisation board, chaired by NICE’s Chief Medical Officer.

NICE intends to carry out focussed updates to all diabetes guidance to take account of changes in insulin availability, but has no current plans for further updates to its guidelines on type 1 diabetes or eating disorders.

I refer the hon. Member to the answer I gave on 13 October 2025 to Question 75637.